Cellectis (CLLS) has released its monthly share capital and voting rights report as of May 31, 2025. The company reported a total of 100,325,229 shares in its capital structure, with 89,110,384 total voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority. The company maintains its listing on Euronext Growth under the ISIN code FR0010425595.
Loading...
Loading translation...
AI-generated analysis. Not financial advice.
Positive
None.
Negative
None.
News Market Reaction – CLLS
-2.08%
1 alert
-2.08%News Effect
On the day this news was published, CLLS declined 2.08%, reflecting a moderate negative market reaction.